In the News
July 2006
Kirkland, Quebec, July 5th, 2006 – Valeo Pharma is proud to announce the launch of a new first-line topical gel treatment for excessive sweating. A unique, highly effective formula, Hydrosal®   is a combination of high concentration aluminum chloride in a proprietary gel that delivers deeper penetration with minimal irritation. Safe, cost-effective, Hydrosal delivers long-term relief.

February 2006
Kirkland, Quebec, February 23, 2006 – Valeo Pharma has acquired Aristospan; a Triamcinolone Hexacetonide Injectable Suspension USP 20mg/ml in November 2003. Therefore due to worldwide shortage difficulties, Aristospan was requiring Special Access Program (SAP) approval.
Valeo Pharma is proud to announce that the potent anti-inflammatory with a prolonged local action has been re-introduced to the Canadian market and is available across Canada.

January 2006
Kirkland, Quebec, January 30, 2006 – Cophylac®; a specialty product for control of intractable cough. Despite its withdrawal from the market in 2000, Valeo Pharma saw an opportunity for this mature brand, which continues to enjoy a small but established franchise in Canada. The pharmaceutical company has searched to custom manufacture the active ingredient; the normethadone, proceeded with development of the formulation, obtained all necessary regulatory approvals.
Cophylac is a proven time-tested antitussive and has a convenient delivery system. The drop dispensing bottle has a specially designed mechanism to properly dispense drops.

November 2004
Valeo Pharma Inc has added two new products Aristocort and Aristospan to its dermatological product portfolio.
Kirkland, Québec, November 3rd, 2004 - Valeo Pharma Inc., a fully integrated specialty pharmaceutical company based in Montreal, announced the recent acquisition of two brands: Aristocort (Triamicinolone Acetonide), primarily used for the treatment of certain dermatoses; and Aristospan (Triamcinolone Hexacetonide), an adjunctive therapy for synovitis of osteoarthritis, acute and subacute bursitis, a product that has not been on the market for the past few [...]